| Literature DB >> 28775257 |
A B Veloso1, J P F Longo2, L A Muehlmann2, B F Tollstadius2, P E N Souza1, R B Azevedo2, P C Morais1,3, S W da Silva4.
Abstract
In this study Surface Enhanced Raman Spectroscopy (SERS) data recorded from mouse mammary glands cancer cells (4T1 cell line) was used to assess information regarding differences between control, death and viable cells after Photodynamic Therapy (PDT) treatment. The treatment used nanoemulsions (NE/PS) loaded with different chloroaluminumphthalocyanine (ClAlP) photosensitizer (PS) contents (5 and 10 µmol × L-1) and illumination (660 nm wavelength) at 10 J × cm-2 (10 minutes). The SERS data revealed significant molecular alterations in proteins and lipids due to the PDT treatment. Principal Component Analysis (PCA) was applied to analyze the data recorded. Three-dimensional and well reproductive PCA scatter plots were obtained, revealing that two clusters of dead cells were well separated from one another and from control cluster. Overlap between two clusters of viable cells was observed, though well separated from control cluster. Moreover, the data analysis also pointed out necrosis as the main cell death mechanism induced by the PDT, in agreement with the literature. Finally, Raman modes peaking at 608 cm-1 (proteins) and 1231 cm-1 (lipids) can be selected for follow up of survival rate of neoplastic cells after PDT. We envisage that this finding is key to contribute to a quick development of quantitative infrared thermography imaging.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28775257 PMCID: PMC5543153 DOI: 10.1038/s41598-017-07469-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Schematic diagram of the nanoemulsion complex preparation (drug carrier system) (a), the PDT protocol used in the in vitro assay (b), and the SERS probe approach (c).
Figure 2Average SERS spectra of 4T1 breast cancer cells for control group and cells treated with the NE/PS5 and NE/PS10 complexes. Each spectrum represents an average of 30 spectra recorded from cellular samples. In the low energy region (400–1100 cm−1) the band intensities were multiplied by 10. The inserted pictures emphasize the vibrational modes related to the protein disulfide bonds (-S-S-) at ~525 cm−1 and DNA fragmentation responsible for the SERS intensity variation associated with phosphodiester bonds (~813 cm−1) and guanine/adenine bases (~1565 cm−1).
SERS bands observed in the spectra recorded from the 4T1 breast cancer cells and the corresponding tentative assignments.
| Raman peak [cm−1] | Assignments | |||
|---|---|---|---|---|
| Protein | Lipid | DNA | Other | |
| 410 | PtdIns& | |||
| 456 | ring torsion, Phe& | |||
| 485 | DNA& | |||
| 520 | (-S-S-)& | |||
| 533 | C=C& | |||
| 549 | (-S-S-)& | |||
| 586 | OH& | |||
| 593 | PtdIns& | |||
| 608 | C-C, twist Phe& | |||
| 638 | C-C, twist Tyr& | |||
| 655 | T, G* | CH2, out-plane bend+ | ||
| 685 | ring def | |||
| 718 | C-N*§ Phospholipid | |||
| 765 | Trp* | |||
| 813 | str (O-P-O)* | |||
| 828 | ring breath, Tyr§ | str ass (O-P-O)* | ||
| 846 | ring breath, Tyr§ | |||
| 973 | C-C, str-sheet | CH bend | ||
| 1003 | Phe*§ | |||
| 1030 | Phe*§ | |||
| 1051 | (C–C) str | C-O, C-C* | ||
| 1077 | PO2 −§ | |||
| 1122 | C-N, str Peptide§ | |||
| 1153 | C-C/C-N, str | Glycogen+ | ||
| 1173 | C-H, bend Tyr* | |||
| 1199 | C-C6H4, Phe, Trp+ | |||
| 1230 | CH bend§ | |||
| 1253 | Amide III*§ | T, A* | ||
| 1325 | CH, def | G* | ||
| 1337 | CH, def+ | |||
| 1375 | A, G+ | |||
| 1404 | CH3, colog+ | Triglyceride+ | ||
| 1434 | CH def | G, A, CH, def | ||
| 1488 | CH, def § | DNA+ | ||
| 1500 | CH, in plane& | |||
| 1565 | G, A+ | |||
| 1591 | C-N, NH2 + | |||
| 1623 | C=C, Tyr, Trp+ | |||
| 1661 | Amide I* | str (C=C)* | ||
Ref. 33*; 34 +; 35 §; 36 & (Phe: Phenylalanine; Tyr: Tyrosine, Trp: Tryptophan; PtdIns: Phosphatidylinositid).
Figure 3Comparison between the values of average intensities and standard deviations of SERS peaks related to proteins (a) and lipids (b). Spectral details are shown in (c and d) for proteins and lipids, respectively.
Figure 4SERS spectra of 4T1 breast cancer cells groups: control and viable and dead cells PDT treated using the NE/PS10 complex. Solid lines are spectral averages.
Figure 5Raman peak area ratio (viable/dead cells) related to (a) proteins and (b) lipids. Data were collected for cells treated using both complexes (NE/PS5 and NE/PS10).
Figure 6PCA scatter plots of the 4T1 breast cancer cells groups: control and dead (a), control and viable (b), control and treated with NE/PS5 (c), and control and treated with NE/PS10 (d). A comparison among all five cells groups is shown in (e).